ArticleKidney diseases (Basel, Switzerland)2019

Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease.

Kennosuke Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.